IOVA
Iovance Biotherapeutics Inc
10.20$
-4.2%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | -123,007.1% | -30,430.6% | -215.1% | -114.8% | |
| – | – | – | – | – | – | – | – | 8,880.3% | 2,786.1% | 26.6% | 13.1% | |
| – | – | – | – | – | – | – | – | 35,303.4% | 5,267.0% | 66.8% | 23.4% | |
| – | – | – | – | – | – | – | – | 35,669.3% | – | – | – | |
| – | – | – | – | – | – | – | – | -1,215.1% | -548.4% | -74.7% | -9.2% | |
| – | – | – | – | – | – | – | – | 8,581.9% | 1,874.7% | 6.7% | 12.8% | |
| – | – | – | – | – | – | – | – | 107,754.2% | -13,056.5% | -58.8% | 18.0% | |
| – | – | – | – | – | – | – | – | -1,113.0% | 202.7% | – | 0.6% | |
| – | – | – | – | – | – | – | – | 0.0% | 0.0% | – | – | |
| – | – | – | – | – | – | – | – | 79,895.0% | 38,936.8% | 238.1% | 114.1% | |
| – | – | – | – | – | – | – | – | 64,642.0% | -4,780.7% | -36.1% | 18.0% | |
| – | – | – | – | – | – | – | – | -131,589.1% | -32,305.3% | -221.9% | -127.6% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.